发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 355 |
| Canada | 37 |
| France | 33 |
| England | 30 |
| GERMANY (FED REP GER) | 29 |
| Italy | 26 |
| Australia | 22 |
| Spain | 22 |
| Japan | 16 |
| Netherlands | 16 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| HARVARD UNIVERSITY | 67 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 51 |
| UNIVERSITY OF TEXAS SYSTEM | 51 |
| DANA-FARBER CANCER INSTITUTE | 44 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 42 |
| FOUNDATION MEDICINE | 33 |
| CORNELL UNIVERSITY | 32 |
| MAYO CLINIC | 26 |
| BRIGHAM & WOMEN'S HOSPITAL | 24 |
| UNICANCER | 24 |
文章引用情况
1
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer2
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy3
Complete and Prolonged Response to Immune Checkpoint Blockade in POLE-Mutated Colorectal Cancer4
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors5
Genomic Landscape of Appendiceal Neoplasms6
Validation of HER2 Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer7
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer8
Plasma Cell-Free DNA Testing of Patients With EGFR Mutant Non-Small-Cell Lung Cancer: Droplet Digital PCR Versus Next-Generation Sequencing Compared With Tissue-Based Results9
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience10
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer